WILLIAM ROSE - 23 Aug 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
Director
Signature
/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose
Issuer symbol
N/A
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
4
Filing time
24 Aug 2023, 16:41:33 UTC
Previous filing
09 Jun 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Gift $0 -500,000 -57% $0.000000 379,281 23 Aug 2023 By trust F1, F2
holding RETA Class A common stock 11,618 23 Aug 2023 Direct F3
holding RETA Class A common stock 19,795 23 Aug 2023 Direct F4
holding RETA Class A common stock 7,886 23 Aug 2023 See Footnote F5
holding RETA Class A common stock 20 23 Aug 2023 By trust F6
holding RETA Class A common stock 45 23 Aug 2023 By trust F7
holding RETA Class A common stock 29 23 Aug 2023 See Footnote F8
holding RETA Class A common stock 180,909 23 Aug 2023 See Footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the donative transfer of shares of Class A common stock. On August 23, 2023, these 500,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family charitable foundation.
F2 These shares are owned directly by the Evelyn Potter Rose Survivor's Trust, for which Charles E. Gale and Evelyn P. Rose serve as co-trustees.
F3 These shares are owned directly by William E. Rose, a director of the issuer.
F4 These shares are owned directly by Charles E. Gale.
F5 These shares are owned directly by Evelyn P. Rose Fidelity SEP IRA and indirectly by Evelyn R. Rose.
F6 These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the Charles Henry Rose 2001 Trust.
F7 These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the John William Rose 2002 Trust.
F8 These shares are owned directly by the Charles E. Gale Fidelity Rollover IRA and indirectly by Charles E. Gale.
F9 These shares are owned directly by Montrose Investments I, L.P. ("Montrose"), and indirectly by William E. Rose, a director of the issuer, as sole shareholder and sole manager of the general partner of Montrose.